EcoDrugPlus

Bcl-2-Like Protein 1

Ensembl ID : ENSOKIG00005031838
Gene Symbol: LOC109907974
3 Cross references
221 Possible Orthologues:

Beta-1 Adrenergic Receptor

Ensembl ID : ENSOKIG00005009298
Gene Symbol: LOC109895889
2 Cross references
191 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSOKIG00005037279
Gene Symbol: LOC109880021
3 Cross references
186 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSOKIG00005002209
Gene Symbol: LOC109893000
3 Cross references
186 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSOKIG00005026111
Gene Symbol: LOC116353566
3 Cross references
190 Possible Orthologues:

Beta-Parvin

Ensembl ID : ENSOKIG00005027962
Gene Symbol: LOC109867703
3 Cross references
181 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSOKIG00005027369
Gene Symbol: BACE1
3 Cross references
212 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSOKIG00005041550
Gene Symbol: LOC109905527
3 Cross references
212 Possible Orthologues:

Bifunctional Epoxide Hydrolase 2-Like

Ensembl ID : ENSOKIG00005008491
Gene Symbol: LOC109904342
2 Cross references
198 Possible Orthologues:

Bifunctional Epoxide Hydrolase 2-Like

Ensembl ID : ENSOKIG00005002318
Gene Symbol: LOC109893829
3 Cross references
197 Possible Orthologues:

Bile Acid Receptor

Ensembl ID : ENSOKIG00005011287
Gene Symbol: LOC109889523
3 Cross references
381 Possible Orthologues:

Bile Acid Receptor-Like

Ensembl ID : ENSOKIG00005047676
Gene Symbol: LOC109867617
3 Cross references
381 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).